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INTRODUCTION 
We have previously shown that the presence of a polymorphism at 
codon 10, nucleotide 29 T>C, in the TGFB1 gene in patients has a 
significant impact on the outcome of unrelated donor allogeneic 
stem cell transplantation by increasing non relapse mortality and 
overall mortality in individuals with a CC genotype. The biological 
significance of this polymorphism is not well understood, however 
t h e i n t e r a c t i o n b e t w e e n T G F -β 1 a n d r e g u l a t o r y 
CD4+CD25+FOXP3+ T cells (Tregs) is well known.  
 
MATERIALS AND METHODS 
To investigate this further we analysed the activation phenotype of 
Tregs in terms of LAP-bound TGF-β1 membrane expression, active 
TGF-β1 secretion and the suppressive capability of these cells in 
correlation with TGFB1 codon 10 T/C genotype. We isolated Tregs 
and effector CD4 T cells by MiniMACS® technology (Miltenyi 
Biotec, Germany) from healthy donors bearing the 3 genotypes (2 
C/C, 3 T/T and 3 T/C). Membrane LAP expression after polyclonal 
activation was measured at different time points by flow cytometry 
analysis. Similarly, we measured TGF-β1 in the supernatant of the 
activated Tregs by Luminex® technology (Luminex Corp., USA). 
Simultaneously, in a subset of samples, we studied Treg 
autologous suppression activity by radioactive thymidine 
incorporation.  
RESULTS 
We observed that LAP expression in CD4+/CD25+/FOXP3+ 
cells peaked between 24 and 48 hours (13-20%) and kept 
high levels up to 96 hours with similar kinetics between 
different genotypes (Figures 1-2). TGF-β1 secretion had a 
later peak between 96 and 216 hours (Figure 3). 
Compellingly, we found that Tregs from C/C individuals 
showed significantly higher suppression capability (Figure 4) 
(95%) compared to T/T (70%) cells (p=0.013).  
 
CONCLUSIONS 
In conclusion, we found a higher suppressive capability of 
Tregs in samples with a TGFB1 codon 10 C/C genotype, 
which may explain our observations of a worse transplant 
outcome in these individuals. We hypothesise that higher 
suppression could impair patients’ response to infection. We 
are currently conducting additional cellular and Q-PCR 
experiments in order to further clarify the effect of this 
polymorphism on TGF-β1. Moreover, we are also analysing 
the in vivo expression of LAP by Tregs in patients after an 
allogeneic-HSCT. 
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FIGURE	  1.	  Induced	  LAP	  expression	  in	  polyclonally	  
s?mulated	  Tregs.	  (FL4-­‐4:	  αCD4)	  
FIGURE	  2.	  Propor?on	  of	  LAP+	  cells	  in	  polyclonally	  
s?mulated	  Tregs	  of	  diﬀerent	  TGFB1	  codon	  10	  
genotypes.	  	  
FIGURE	  4.	  Suppressive	  capability	  of	  Tregs	  of	  diﬀerent	  
TGFB1	  codon	  10	  genotypes.	  (*p=0.013)	  
FIGURE	  3.	  TGF-­‐beta	  levels	  in	  supernatants	  of	  
polyclonally	  s?mulated	  Tregs	  of	  diﬀerent	  TGFB1	  
codon	  10	  genotypes.	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